Bisphosphonates: do we know their role in adjuvant breast cancer treatment?
Barginear
Myra F
MF
Department of Hematology and Medical Oncology, Mount Sinai School of Medicine, New York, New York, USA.
Van Poznak
Catherine
C
D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control*
D050071:Bone Density Conservation Agents; D004164:Diphosphonates